Literature DB >> 25730606

Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation.

Emily C O'Brien1, Sunghee Kim1, Paul L Hess1, Peter R Kowey2, Gregg C Fonarow3, Jonathan P Piccini1, Eric D Peterson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25730606     DOI： 10.1001/jamainternmed.2015.13

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  9 in total

1.  Application of net reclassification index to non-nested and point-based risk prediction models: a review.

Authors:  Laine E Thomas; Emily C O'Brien; Jonathan P Piccini; Ralph B D'Agostino; Michael J Pencina
Journal:  Eur Heart J       Date:  2019-06-14       Impact factor: 29.983

2.  Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.

Authors:  Lars J Kjerpeseth; Hanne Ellekjær; Randi Selmer; Inger Ariansen; Kari Furu; Eva Skovlund
Journal:  Eur J Clin Pharmacol       Date:  2017-07-22       Impact factor: 2.953

3.  CHAD is Dead: Pragmatic Utility of the CHA2DS2-VASc Score in Non-Valvular Atrial Fibrillation?

Authors:  T Raymond Foley; Mori J Krantz
Journal:  J Gen Intern Med       Date:  2018-01       Impact factor: 5.128

4.  Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.

Authors:  Lars J Kjerpeseth; Hanne Ellekjær; Randi Selmer; Inger Ariansen; Kari Furu; Eva Skovlund
Journal:  Eur J Clin Pharmacol       Date:  2018-08-16       Impact factor: 2.953

5.  Sex-differences in post-discharge outcomes among patients hospitalized for atrial fibrillation.

Authors:  Bindu Kalesan; Amartya Kundu; Aditya Vaze; Elizabeth Pino; Allan J Walkey; Ramachandran S Vasan; David D McManus
Journal:  Clin Cardiol       Date:  2018-12-19       Impact factor: 2.882

6.  Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registries.

Authors:  Zak Loring; Suchit Mehrotra; Jonathan P Piccini; John Camm; David Carlson; Gregg C Fonarow; Keith A A Fox; Eric D Peterson; Karen Pieper; Ajay K Kakkar
Journal:  Europace       Date:  2020-11-01       Impact factor: 5.214

7.  Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation.

Authors:  Xiaoxi Yao; Jonathan W Inselman; Joseph S Ross; Rima Izem; David J Graham; David B Martin; Aliza M Thompson; Mary Ross Southworth; Konstantinos C Siontis; Che G Ngufor; Karl A Nath; Nihar R Desai; Brahmajee K Nallamothu; Rajiv Saran; Nilay D Shah; Peter A Noseworthy
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-10-05

8.  Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study.

Authors:  Mary E Tinetti; Gail McAvay; Mark Trentalange; Andrew B Cohen; Heather G Allore
Journal:  BMJ       Date:  2015-10-02

9.  Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.

Authors:  Matthew P Gray; Samir Saba; Yuting Zhang; Inmaculada Hernandez
Journal:  J Am Heart Assoc       Date:  2018-01-04       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.